Cargando…
Nonmedical switching of anticoagulants: The patient impact when formulary exclusions limit drug choice
Autor principal: | Waldron, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922952/ https://www.ncbi.nlm.nih.gov/pubmed/35316939 http://dx.doi.org/10.1002/rth2.12675 |
Ejemplares similares
-
A Prescription for Improving Drug Formulary Decision Making
por: Schiff, Gordon D., et al.
Publicado: (2012) -
The state of the antivaccine movement in the United States: A focused examination of nonmedical exemptions in states and counties
por: Olive, Jacqueline K., et al.
Publicado: (2018) -
Apixaban returned to CVS Caremark formulary after outcry
por: Waldron, Beth
Publicado: (2022) -
Choice or no choice? The need for better branded public sector condoms in South Africa
por: Ashmore, John, et al.
Publicado: (2015) -
Switching to Switchgrass
por: Tenenbaum, D
Publicado: (2002)